Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis

@inproceedings{Mease2014ManagingPW,
  title={Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis},
  author={Philip J Mease and April W Armstrong},
  booktitle={Drugs},
  year={2014}
}
Psoriatic arthritis (PsA) is a chronic, systemic inflammatory disease. Up to 40 % of patients with psoriasis will go on to develop PsA, usually within 5–10 years of cutaneous disease onset. Both conditions share common pathogenic mechanisms involving genetic and environmental factors. Because psoriasis is typically present for years before PsA-related joint symptoms emerge, dermatologists are in a unique position to detect PsA earlier in the disease process through regular, routine screening of… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 11 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Secukinumab: A Review in Psoriatic Arthritis

View 5 Excerpts
Highly Influenced

Diagnosis and management of psoriasis.

Canadian family physician Medecin de famille canadien • 2017

References

Publications referenced by this paper.
Showing 1-10 of 193 references

Harnessing dendritic cells in inflammatory skin diseases

Seminars in immunology • 2011
View 13 Excerpts
Highly Influenced

Cyclic AMP: master regulator of innate immune cell function.

American journal of respiratory cell and molecular biology • 2008
View 7 Excerpts
Highly Influenced

Psoriasis and psoriatic arthritis: separate or one and the same?

The British journal of dermatology • 2007
View 8 Excerpts
Highly Influenced

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

The Journal of clinical investigation • 2008
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…